| Literature DB >> 35816473 |
Anne Krause1,2, Kyungsoo Lee1, Daniel König1,3, Michael Faist4, Kathrin Freyler1, Albert Gollhofer1, Ramona Ritzmann1,5.
Abstract
People with multiple sclerosis (MS) suffer from sensorimotor deficits with the distal extremities being more severely affected than proximal ones. Whole-body vibration (WBV) training is known to enhance voluntary activation and coordination in healthy people. However, evidence about beneficial effects of WBV in MS patients is scarce. The current study aimed to investigate if six weeks of WBV enhances motor function in the ankle joint, coordination and quality of life in patients suffering from severe MS. In a longitudinal design, changes in motor function and quality of life were assessed before and after a 6-week control period without a training (CON) and a 6-week WBV training (2-3x/week) in 15 patients (53 ±10 years) with advanced MS (EDSS 3-6.5). Before CON (t0), after CON (t1) and after WBV(t2), outcome measures included (1) active range of motion (aROM) and (2) motor accuracy at the ankle joint, (3) functional mobility (Timed "Up & Go" test with preferred and non-preferred turns) and (4) physical and psychological impact of MS (MSIS-29 questionnaire). For (1) and (2), the stronger (SL) and the weaker leg (WL) were compared. After WBV, aROM (1) did not change (SL p = 0.26, WL p = 0.10), but was diminished after CON (SL -10% p = 0.06, WL -14% p = 0.03) with significant group differences (Δgroup WL p = 0.02). Motor accuracy in SL (2) was improved during dorsal flexion after WBV (p = 0.01, Δgroup p = 0.04) and deteriorated during plantar flexion after CON (p = 0.01, Δgroup p = 0.04). Additionally, participants (3) improved their functional mobility at the preferred turn (p = 0.04) and (4) ranked their quality of life higher solely after WBV (p = 0.05), without any differences between groups. However, values correlated significantly between angular precision and aROM as well as functional mobility. No further changes occurred. The results point towards an interception of degenerating mono-articular mobility and improvement of accuracy in the ankle joint. The motor effects after WBV are in line with enhanced perception of quality of life after six weeks which is why WBV could be a stimulus to enable greater overall autonomy in MS patients.Entities:
Mesh:
Year: 2022 PMID: 35816473 PMCID: PMC9273076 DOI: 10.1371/journal.pone.0270698
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Fig 1Flow chart diagram.
Characteristics of participants.
| Values | |
|---|---|
|
| 11/4 |
|
| 53 ± 4 |
|
| 5.5 (4–6) |
|
| 170 ± 9 |
|
| 73 ± 2 |
Fig 2Overview of the applied assessments.
The assessments included (1) angular mobility by means of aROM measures in the ankle joint using electro-goniometry and (2) motor accuracy by means of plantarflexion and dorsal extension with biofeedback. Additionally, (3) functional mobility was assessed by means of the Timed “Up & Go” test (TUG) and (4) impact of MS with the Multiple Sclerosis Impact Scale (MSIS-29).
Fig 3Assessment setup for motor accuracy.
Participants sat upright in a chair and were asked to flex and extend their ankle joint (A). Fixations were provided at the knee and ankle; the ankle joint was in line with the rotation axis of the ergometer. Ankle joint position was visualized for plantarflexion and dorsal extension (B) as biofeedback. Participants were asked to replicate the predefined (grey) curve with as accurately as possible (black). Errors were calculated by means of differences between the predefined curve and the position signal in Δ°.
Results of angular mobility and motor accuracy for the active range of motion (top) and motor precision task (bottom) of the ankle joint.
| ΔCON | ΔWBV | Δgroups | ||||||
|---|---|---|---|---|---|---|---|---|
| t0 | t1 | t2 | p |
| p |
| p | |
| AnkleSL [°] | 52.9 ±23.4 | 47.4 ± 24.2 | 57.9 ±30.3 | 0.06 | 0.26 | 0.12 | ||
| [37.16; 68.66] | [31.09; 63.61] | [37.52; 78.28] | ||||||
| AnkleWL [°] |
| 48.4 ± 10.3 | 53.5 ±9.7 |
| 0.10 |
| ||
|
| [41.48; 55.28] | [46.99; 60.08] | ||||||
| Error PFSL [a.U.] |
| 0.047 ±0.013 | 0.040 ±0.009 |
| 0.08 |
| ||
| [0.03; 0.05] | [0.04; 0.05] | [0.03; 0.05] | ||||||
| Error DFSL [a.U.] | 0.056 ±0.022 | 0.055 ±0.015 |
| 0.90 |
|
| ||
| [0.04; 0.07] | [0.05; 0.06] | [0.04; 0.05] | ||||||
| Error PFWL[a.U.] | 0.041 ±0.011 | 0.040 ±0.010 | 0.036 ±0.007 | 0.79 | 0.06 | 0.29 | ||
| [0.03; 0.05] | [0.03; 0.05] | [0.03; 0.04] | ||||||
| Error DFWL[a.U.] | 0.049 ±0.018 | 0.050 ±0.016 | 0.051 ±0.013 | 0.91 | 0.40 | 0.41 | ||
| [0.04; 0.06] | [0.04; 0.06] | |||||||
Listed are all mean values ± standard deviations and 95% CI in square brackets before (t0) and after six weeks of no intervention (t1, ΔCON), as well as after six weeks of whole-body vibration intervention (t2, ΔWBV). Significant results are highlighted in bold letters. Cohen’s d is presented with small (0.2 < d < 0.5), medium (0.5 < d < 0.8) and large effects sizes (d > 0.8). Note that motor accuracy increases with reduced error values. P values for differences between groups are listed in the last column as Δ groups.
CON = Control period; WBV = Whole-body vibration intervention; PF = Plantar flexion; DF = Dorsal flexion; SL = Stronger leg; WL = Weaker leg; Δ = Differences
Fig 4Angular mobility and motor accuracy.
The graphs illustrate changes of mono-articular mobility (A) and motor accuracy (B) prior (t0), after six weeks of no intervention (t1) as well as after six weeks of WBV (t2). “A” shows significant changes with an asterisk of active range of motion (aROM) in [°] for the ankle joint of the stronger leg (AJSL) and weaker leg (AJWL). “B” illustrates errors (in [V]) during fine motor tasks for the plantar flexion (PF) and dorsal flexion (DF) with the stronger leg (SL, dark grey) and the weaker leg (WL, light grey).
Results of functional mobility and impact of MS during everyday life for the Timed “Up & Go” test (top) and for the MSIS-29 questionnaire scores (bottom).
| ΔCON | ΔWBV | Δgroups | ||||||
|---|---|---|---|---|---|---|---|---|
| t0 | t1 | t2 | p |
| p |
| p | |
| TUG [s] | 14.6 ±6.3 | 13.6 ± 5.5 | 12.5 ±4.4 | 0.09 | 0.34 | 0.48 | ||
| [10.06; 19.10] | [9.64; 17.51] | [9.35; 15.62] | ||||||
| TUGpreferred [s] | 15.1 ±6.7 | 13.9 ± 6.0 |
| 0.19 |
| 0.44 | ||
| [10.33; 19.86] | [9.60; 18.14] |
| ||||||
| TUGnon-preferred [s] | 14.1 ±6.0 | 13.3 ± 5.2 | 12.6 ±4.9 | 0.13 | 0.32 | 0.40 | ||
| [9.77; 18.36] | [9.57; 16.99] | [9.08; 16.08] | ||||||
| MSIS-29 total score [a.U.] | 2.56 |
| 0.23 |
| 0.19 | |||
| MSIS-29 Phy. score [a.U.] | 2.93 |
| 0.18 |
| 0.13 | |||
| MSIS-29 Psy. score [a.U.] | 2.50 | 1.72 | 0.44 | 0.11 | 0.44 | |||
Listed are all mean values ± standard deviations 95% CI in square brackets for Timed “Up & Go” and median values for MSIS-29 before (t0) and after six weeks of no intervention (t1, CON), as well as after six weeks of whole-body vibration intervention (t2, WBV). Significant results are listed with p < 0.05 in bold letters. Cohen’s d is presented with small (0.2 < d < 0.5), medium (0.5 < d < 0.8) and large effects sizes (d > 0.8). P values for differences between groups are listed in the last column as Δ groups.
CON = Control period; WBV = Whole-body vibration intervention; TUG = Timed “Up & Go” test; MSIS-29 = Multiple Sclerosis Impact Scale 29; Phy. = Physical; Psy. = Psychological